Cabinet approves Mylan's deal to buy Strides unit - Tewari

NEW DELHI (Reuters) - The cabinet on Tuesday approved Mylan Inc's
Mylan, one of the world's largest generic drugmakers, in February agreed to buy the Strides unit, Agila Specialities, for $1.6 billion to expand its presence in the fast-growing injectable drugs market.
(Reporting by Nigam Prusty)
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 03 2013 | 7:46 PM IST
